Dogwood Therapeutics, Inc.
DWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818844
No open-market purchases or sales by Dogwood Therapeutics, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $6.16M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Dogwood Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 10
- −13 vs. Q3 2024
- Shares held
- 30.8K
- −1.00M (−97.0%) vs. Q3 2024
- Total value
- $76.5K
- −$98.6K (−56.3%) vs. Q3 2024
- New holders
- 1
- 0 more added
- Sold out
- 14
- 9 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $6.16M |
| Q1 2026 | 13 | $7.64M |
| Q4 2025 | 10 | $292.0K |
| Q3 2025 | 12 | $299.5K |
| Q2 2025 | 10 | $207.5K |
| Q1 2025 | 13 | $409.8K |
| Q4 2024 | 10 | $76.5K |
| Q3 2024 | 24 | $180.3K |
| Q2 2024 | 24 | $212.0K |
| Q1 2024 | 20 | $324.9K |
| Q4 2023 | 20 | $493.4K |
| Q3 2023 | 23 | $766.3K |
| Q2 2023 | 24 | $1.08M |
| Q1 2023 | 23 | $307.1K |
| Q4 2022 | 27 | $307.7K |
| Q3 2022 | 25 | $485.7K |
| Q2 2022 | 17 | $4.80M |
| Q1 2022 | 15 | $4.91M |
| Q4 2021 | 16 | $4.85M |
| Q3 2021 | 13 | $5.30M |
| Q2 2021 | 14 | $5.58M |
| Q1 2021 | 14 | $5.06M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Dogwood Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 17,671 | $44.0K | 0.00% | −168,391−90.5% | Reduced |
| Geode Capital Management, LLC | 10,933 | $27.1K | 0.00% | −219,817−95.3% | Reduced |
| Tower Research Capital LLC (TRC) | 972 | $2.42K | 0.00% | −5,851−85.8% | Reduced |
| Morgan Stanley | 600 | $1.49K | 0.00% | −14,601−96.1% | Reduced |
| Northwestern Mutual Wealth Management Co | 381 | $949 | 0.00% | −18,681−98.0% | Reduced |
| Activest Wealth Management | 120 | $299 | 0.00% | −2,880−96.0% | Reduced |
| Group One Trading, L.P. | 45 | $112 | 0.00% | −1,252−96.5% | Reduced |
| BlackRock, Inc. | 30 | $75 | 0.00% | −725−96.0% | Reduced |
| Bank of America Corp | 10 | $25 | 0.00% | −201−95.3% | Reduced |
| SBI Securities Co., Ltd. | 8 | $20 | 0.00% | +8 | New |
| Vanguard Group Inc | 0 | $0 | 0.00% | −208,883−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −81,574−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −53,392−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −52,828−100.0% | Sold out |
| McCollum Christoferson Group LLC | 0 | $0 | 0.00% | −33,500−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −28,032−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −24,035−100.0% | Sold out |
| Regions Financial Corp | 0 | $0 | 0.00% | −20,072−100.0% | Sold out |
| One + One Wealth Management, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −16,500−100.0% | Sold out |
| William Howard & Co Financial Advisors Inc | 0 | $0 | 0.00% | −10,072−100.0% | Sold out |
| Wiley Bros.-Aintree Capital, LLC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −10,582−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Raymond James & Associates | – | – | – | – | Not filed |